K Number
K233761
Device Name
Orthopaedic Surgery Planning Software (AIJOINT)
Date Cleared
2024-08-05

(255 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
This product is used in medical institutions, it can carry out 3D reconstruction, segmentation and semi-automatic identification of key points on CT images conforming to DICOM3.0 standard format, and assist physicians to overlay digital templates to assist surgeons with preoperative planning of adult hip and total knee replacement surgery. This product is intended for use by trained and qualified physicians and cannot be used as a basis for clinical diagnosis and treatment decisions alone.
Device Description
The proposed device, Orthopaedic Surgery Planning Software, is standalone software which is designed to help surgeons' specialists carry out the pre-operative planning for an adult hip and total knee replacement surgery for several surgical procedures, based on the patient's CT images. The Orthopaedic Surgery Planning Software can a carry out 3D reconstruction, segmentation and semi-automated identification of anatomical sites of CT images conforming to DICOM3.0 standard format, and assist physicians to simulate adult hip and total knee replacement surgery.
More Information

Unknown
The summary mentions "semi-automated identification of anatomical sites" and "segmentation," which are tasks often performed by AI/ML algorithms in medical imaging. However, it does not explicitly state that AI or ML is used, nor does it provide details about training or test sets that would definitively indicate the use of these technologies. The term "semi-automated" could refer to other image processing techniques.

No.
The device is described as software that assists physicians with "preoperative planning of adult hip and total knee replacement surgery" and "cannot be used as a basis for clinical diagnosis and treatment decisions alone." It is a planning tool, not a device that directly or indirectly treats a disease or condition.

No

The "Intended Use" states that the product "cannot be used as a basis for clinical diagnosis and treatment decisions alone," indicating it is an assistive tool rather than a standalone diagnostic device.

Yes

The device description explicitly states that the proposed device is "standalone software". The intended use and device description focus solely on software functionalities like 3D reconstruction, segmentation, and planning based on CT images. There is no mention of any accompanying hardware components that are part of the medical device itself.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
  • Device Function: This device is software that processes medical images (CT scans) to assist with surgical planning. It does not analyze biological samples from the patient.
  • Intended Use: The intended use is to assist physicians with preoperative planning for hip and knee replacement surgery by processing imaging data. This is a clinical decision support tool based on imaging, not a diagnostic test performed on biological samples.

Therefore, while it is a medical device used in a clinical setting, it falls outside the scope of In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

This product is used in medical institutions, it can carry out 3D reconstruction, segmentation and semi-automatic identification of key points on CT images conforming to DICOM3.0 standard format, and assist physicians to overlay digital templates to assist surgeons with preoperative planning of adult hip and total knee replacement surgery. This product is intended for use by trained and qualified physicians and cannot be used as a basis for clinical diagnosis and treatment decisions alone.

Product codes

LLZ

Device Description

The proposed device, Orthopaedic Surgery Planning Software, is standalone software which is designed to help surgeons' specialists carry out the pre-operative planning for an adult hip and total knee replacement surgery for several surgical procedures, based on the patient's CT images.

The Orthopaedic Surgery Planning Software can a carry out 3D reconstruction, segmentation and semi-automated identification of anatomical sites of CT images conforming to DICOM3.0 standard format, and assist physicians to simulate adult hip and total knee replacement surgery.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

CT images

Anatomical Site

Hip, Knee

Indicated Patient Age Range

adult

Intended User / Care Setting

trained and qualified physicians, medical institutions

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

The accuracy testing of key point recognition, comparing with the key points identified. annotated by professional physicians for precision.

The accuracy testing of image segmentation, comparing with the segmentation results of the mature software available in the market. Testing shows that the mean Dice coefficient and the mean Hausdorff Distance of 200 patient cases (100 cases per region) were 0.9483 and 1.2917.

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Internal verification and validation testing were conducted to verify that the proposed device met all design requirements and was Substantially Equivalent (SE) to the predicate devices.

Validation activities for the proposed device consisted of:

  • The accuracy testing of key point recognition, comparing with the key points identified. annotated by professional physicians for precision. Testing shows that key point coordinates have actual error distance is below 1mm. Bland-Altman plots show that all points are within the 95% CI.
  • The accuracy testing of image segmentation, comparing with the segmentation results of the mature software available in the market. Testing shows that the mean Dice coefficient and the mean Hausdorff Distance of 200 patient cases (100 cases per region) were 0.9483 and 1.2917.
  • The accuracy verification of the output parameters from the proposed device. Testing shows that the accuracy of the output parameters of the orthopedic surgery planning software is within the length measurement accuracy of 1mm and the Angle measurement accuracy of 1°.
  • The verification on the consistency of prosthesis model data. Comparing the self-drawn prosthesis model data and the real prosthesis model data provided by the manufacturer, the deviations are all below 0.5mm.
  • The accuracy verification of the output acetabular cup coverage. Testing shows that the accuracy of the output acetabular cup coverage of the orthopedic surgery planning software is within ±3%.

Software verification and validation were performed, and documentation was provided following the FDA guidance "Content of Premarket Submissions for Device Software Functions." This includes verification against defined requirements, and validation against user needs.

The conclusions drawn from the nonclinical tests demonstrate that the proposed device is as safe, as effective, and performs as well as the legally marketed predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

  • Key point coordinates actual error distance is below 1mm.
  • Mean Dice coefficient and mean Hausdorff Distance of 200 patient cases for image segmentation were 0.9483 and 1.2917.
  • Accuracy of output parameters: length measurement accuracy within 1mm, Angle measurement accuracy within 1°.
  • Deviations between self-drawn and real prosthesis model data: all below 0.5mm.
  • Accuracy of output acetabular cup coverage: within ±3%.

Predicate Device(s)

K182464

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" and "ADMINISTRATION" in blue text.

Longwood Valley Medical Ltd Wei Yuanyuan RA Manager 2201 Floor 22, Tower 1, No.2 Ronghua South Rd., BDA 100176 Beijing, China

August 5, 2024

Re: K233761

Trade/Device Name: Orthopaedic Surgery Planning Software (AIJOINT) Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: LLZ Dated: July 1, 2024 Received: July 1, 2024

Dear Wei Yuanyuan :

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming

1

product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Jessica Lamb

Jessica Lamb, Ph.D. Assistant Director Imaging Software Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

2

Indications for Use

Submission Number (if known)

K233761

Device Name

Orthopaedic Surgery Planning Software (AIJOINT)

Indications for Use (Describe)

This product is used in medical institutions, it can carry out 3D reconstruction, segmentation and semi-automatic identification of key points on CT images conforming to DICOM3.0 standard format, and assist physicians to overlay digital templates to assist surgeons with preoperative planning of adult hip and total knee replacement surgery. This product is intended for use by trained and qualified physicians and cannot be used as a basis for clinical diagnosis and treatment decisions alone.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

K233761-510(k) Summary

Date of Preparation: 7/31/2024

    1. Sponsor Identification

Longwood Valley Medical LTD.

Address: 2201 Floor 22, Tower 1, No.2 Ronghua South Rd., BDA 100176 Beijing, China Contact Person: Peng Chen Position: RA manager Tel: +86 13511033835 Email: pchen@changmugu.com

    1. Designated Submission Correspondent
      Mr. Peng Chen (Primary Contact Person) Ms. Yuanyuan Wei (Alternative Contact Person)

Longwood Valley Medical LTD.

2201 Floor 22, Tower 1, No.2 Ronghua South Rd., BDA 100176 Beijing, China

Tel: +86 4001004670 Fax: +86 (010)62692997 Email: pchen@changmugu.com

4

Identification of Proposed Device 3.

Trade Name: Orthopaedic Surgery Planning Software (AIJOINT) Common Name: Pre-operative planning software

Regulatory Information

Regulation Name: Medical image management and processing system Classification: Class II Product Code: LLZ Regulation Number: 21 CFR 892.2050 Review Panel: Radiology

Indication for Use:

This product is used in medical institutions, it can carry out 3D reconstruction, segmentation and semi-automatic identification of key points on CT images conforming to DICOM3.0 standard format, and assist physicians to overlay digital templates to assist surgeons with preoperative planning of adult hip and total knee replacement surgery. This product is intended for use by trained and qualified physicians and cannot be used as a basis for clinical diagnosis and treatment decisions alone.

  • Identification of Predicate Devices 4.
    510(k) Number: K182464 Product Name: PeekMed

Indications for Use:

PeekMed is a software system designed to help surgeons' specialists carry out the pre-operative planning in a prompt and efficient manner for several surgical procedures, based on their patients' imaging studies.

The software imports diagnostics imaging studies such as x-rays, CT or magnetic resonance image (MRI). The import process can retrieve files from a CD ROM, a local folder or the PACS. In parallel, there is a database of digital representations related to prosthetic materials supplied by their producing companies.

PeekMed allows health professional to digitally perform the surgical planning without adding any additional steps to that process. This software system requires no imaging study acquisition specification (no protocol). Experience in usage and a clinical assessment are necessary for a proper use of the software.

Device Description న్.

The proposed device, Orthopaedic Surgery Planning Software, is standalone software which is designed to help surgeons' specialists carry out the pre-operative planning for an adult hip and total

5

knee replacement surgery for several surgical procedures, based on the patient's CT images.

The Orthopaedic Surgery Planning Software can a carry out 3D reconstruction, segmentation and semi-automated identification of anatomical sites of CT images conforming to DICOM3.0 standard format, and assist physicians to simulate adult hip and total knee replacement surgery.

Substantially Equivalent (SE) Comparison 6.

ITEMProposed DevicePredicate Device K182464Remark
Product nameOrthopaedic
Surgery
Planning SoftwarePeekMed/
Regulation No.21 CFR 892.205021 CFR 892.2050Same
Product CodeLLZLLZSame
ClassIIIISame
Intended for UseA pre-operative planning
software for surgeryA pre-operative planning
software for surgerySame
Indication for UseThis product is used in
medical institutions, it can
carry out 3D
reconstruction,
segmentation and
semi-automatic
identification of key points
on CT images conforming
to DICOM3.0 standard
format, and assist
physicians to overlay
digital templates to assist
surgeons with preoperative
planning of adult hip and
total knee replacement
surgery. This product is
intended for use by trained
and qualified physicians
and cannot be used as a
basis for clinical diagnosis
and treatment decisionsPeekMed is a software system
designed to help surgeons'
specialists carry out the
pre-operative planning in a
prompt and efficient manner for
several surgical procedures, based
on their patients' imaging studies.
The software imports diagnostics
imaging studies such as x-rays,
CT or magnetic resonance image
(MRI). The import process can
retrieve files from a CD ROM, a
local folder or the PACS. In
parallel, there is a database of
digital representations related to
prosthetic materials supplied by
their producing companies.
PeekMed allows health
professional to digitally perform
the surgical planning without
adding any additional steps toSimilar
Analysis
1
alone.that process. This software
system requires no imaging study
acquisition specification (no
protocol). Experience in usage
and a clinical assessment are
necessary for a proper use of the
software.
PeekMed allows the surgeon to
perform the pre-surgical planning
AIJOINT allows theefficiently in the following
surgeon to perform thesubspecialties:
pre-surgical planning
efficiently in the following- Hip
subspecialties:- Knee
- Hip- Spine
- Upper Limb
- Knee- Foot and Ankle
- Trauma
For each subspecialty, there are
For each subspecialty, thereseveral procedures:
are several procedures:
-Hip:
-Hip:Hip Dysplasia Correction,
Hip Dysplasia Correction,Limb Length Discrepancy,
Limb Length Discrepancy,Center of Rotation - RanawatDifferent
SubspecialtiesAcetabular Angle,method,Analysis
Hip ArthroplastyAcetabular Angle,2
Total Hip Arthroplasty
-Knee: Leg Deformity
-Knee: Knee ArthroplastyCorrection, AP Knee Resection,
AP Full Leg
resection, High Tibial Osteotomy,
ACL Tunnel Reconstruction,
Medial Patellofemoral Ligament
/-Spine: Single Cobb Angle,
Thoracic Kyphosis Angle,
Lumbar Lordosis Angle, Sagittal
Vertical Axis, Pelvic Angles,
Coronal Balance, Sacro- femoral
Angle, Sagittal Balance,
Smith-Petersen
Osteotomy, Pedicle Subtraction Osteotomy
-Upper Limb: Total Shoulder Replacement, Clavicular Angle, Shoulder Resurfacing
-Foot and Ankle: Talar Tilt, Hallux Valgus, Moreau-Costa-Bertani Internal Angle, Moreau- Costa-Bertani External Angle, Maestro Formula
-Trauma: Diaphyseal Shaft Fracture Angle, Metaphyseal Shaft Fracture Angle, Roof Arc
Patient PopulationAdultsAdults and pediatricsDifferent Analysis 3
End UsersSurgeonsSurgeonsSame
ComputerPersonal ComputerPersonal Computer or WorkstationSame
Operating SystemWindowsWindows or OS XDifferent Analysis 4
Device AvailabilityIt can be set to start from a computer standalone for planning proceduresIt can be set to start from a workstation or standalone for planning proceduresSame
Images SourceReceives medical images from computer local client end.Receives medical images from various sources (including PACS)Same
Data ProcessingThe software processes data in order to provide an overlap and dimensioning of digital representations of the prosthetic materialThe software processes data in order to provide an overlap and dimensioning of digital representations of the prosthetic materialSame

Table 1 Technical Characteristics Comparison

6

7

8

| Digital Overlap of
Prosthetic Material | Allows the overlap of
models and the intersection
of the models | Allows the overlap of models and
the intersection of the models | Same |
|---------------------------------------------------------------------------------|-----------------------------------------------------------------------|--------------------------------------------------------------------|------|
| Interactive Model
Positioning | Yes | Yes | Same |
| Interactive Model
Dimensioning | Yes | Yes | Same |
| Model Rotation | Yes | Yes | Same |
| Support for Digital
Prosthetic Materials
Provided by the
Manufacturers | Yes | Yes | Same |
| Automatic Calibration | Yes | Yes | Same |
| Pre-surgical Planning | Yes | Yes | Same |
| Contact with the
Patient | No | No | Same |
| Control of life
Supporting Devices | No | No | Same |
| Human Intervention for
Image Interpretation | Yes | Yes | Same |

Similar Analysis 1- Indication for Use

Both the proposed device and predicate device are the pre-operative planning software for surgery. Both the proposed device and predicate device have a database of digital representations related to prosthetic materials supplied by their producing companies.

The image source for the proposed device is CT, the image source for the predicate device is CT, x-rays and MRI. The image source for the proposed device is within the scope of the image sources for the predicate device.

The import process for the proposed device can retrieve files from a local folder; The import process for the predicate device can retrieve files from a CD ROM, a local folder or the PACS. The import process for the proposed device is within the scope of the import process for the predicate device.

Based on above analysis, the indication for use of the proposed device is within the scope of the indication for use of the predicate device.

Different Analysis 2- Subspecialties

9

The Subspecialties of the proposed device and the predicate device is different. The proposed device and predicate device are all applicable to the Hip and Knee procedures, although they are applicable to different detail hip/knee procedure, the software verification and validation testing and performance testing demonstrate that the proposed device's safety and effectiveness.

Different Analysis 3- Patient Population

The patient population of the proposed device and the predicate device is different. The users use the proposed device for adult patients according to the indications for use that the difference will not affect the safety and effectiveness of the proposed device.

Different Analysis 4- Operating System

The type of operating system of proposed device is within the types of the predicate device. The difference will not affect the safety and effectiveness of the proposed device.

  • Non-Clinical Test Conclusion 7.
    Internal verification and validation testing were conducted to verify that the proposed device met all design requirements and was Substantially Equivalent (SE) to the predicate devices.

Validation activities for the proposed device consisted of:

  • The accuracy testing of key point recognition, comparing with the key points identified . annotated by professional physicians for precision. Testing shows that key point coordinates have actual error distance is below 1mm. Bland-Altman plots show that all points are within the 95% CI.
  • The accuracy testing of image segmentation, comparing with the segmentation results of the . mature software available in the market. Testing shows that the mean Dice coefficient and the mean Hausdorff Distance of 200 patient cases (100 cases per region) were 0.9483 and 1.2917.
  • . The accuracy verification of the output parameters from the proposed device. Testing shows that the accuracy of the output parameters of the orthopedic surgery planning software is within the length measurement accuracy of 1mm and the Angle measurement accuracy of 1°.
  • The verification on the consistency of prosthesis model data. Comparing the self-drawn ● prosthesis model data and the real prosthesis model data provided by the manufacturer, the deviations are all below 0.5mm.
  • The accuracy verification of the output acetabular cup coverage. Testing shows that the accuracy . of the output acetabular cup coverage of the orthopedic surgery planning software is within ±3%.

Software verification and validation were performed, and documentation was provided following the FDA guidance "Content of Premarket Submissions for Device Software Functions." This includes verification against defined requirements, and validation against user needs.

The conclusions drawn from the nonclinical tests demonstrate that the proposed device is as safe, as

10

effective, and performs as well as the legally marketed predicate devices.

    1. Clinical Test Conclusion
      No clinical study is included in this submission.
    1. Substantially Equivalent (SE) Conclusion
      Based on the comparison and analysis above, the subject device is substantially equivalent to the legally marketed predicate device, K182464.